v3.24.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Summary of Stock Option Activity

Stock option activity is summarized as follows:

 

 

Number of
Outstanding
Stock Options

 

 

Weighted-
Average
Exercise Price

 

 

Weighted
Remaining Contractual Term

 

 

Aggregate
Intrinsic Value

 

Outstanding as of December 31, 2022

 

 

2,956,170

 

 

$

7.45

 

 

 

 

 

 

 

Granted

 

 

1,112,885

 

 

$

2.21

 

 

 

 

 

 

 

Canceled/forfeited/expired

 

 

(112,228

)

 

$

6.42

 

 

 

 

 

 

 

Outstanding as of December 31, 2023

 

 

3,956,827

 

 

$

6.00

 

 

 

7.94

 

 

$

—

 

 

Summary of Assumptions Used to Determine Fair Value of Employee Stock Purchase Plan

The assumptions used in the Black-Scholes option pricing model to determine the fair value of the ESPP offering were as follows:

 

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Expected term (in years)

 

 

0.50

 

 

 

0.50

 

 

 

0.50

 

Risk-free interest rate

 

4.54% – 5.38%

 

 

0.06% – 4.54%

 

 

0.04% – 0.12%

 

Expected volatility

 

40.9% – 58.5%

 

 

51.9% – 95.9%

 

 

89.7% – 108.12%

 

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Schedule of Restricted Stock Units Activity

Occasionally, we grant restricted stock units to employees. The fair value of restricted stock is determined by the closing price of our common stock reported on the Nasdaq Capital Market on the date of grant. Restricted stock unit activity is summarized as follows:

 

 

 

Number of Outstanding
Restricted Stock Units

 

 

Weighted-Average
Grant Date
Fair Value

 

Balance as of December 31, 2022

 

 

121,438

 

 

$

5.09

 

Released

 

 

(58,111

)

 

$

4.69

 

Balance as of December 31, 2023

 

 

63,327

 

 

$

5.45

 

Schedule of Allocation of Stock-Based Compensation for All Options Including Performance Options with Market Condition and Restricted Stock Units

The allocation of stock-based compensation for all options, including performance options with market condition and restricted stock units is as follows (in thousands):

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Research and development

 

$

600

 

 

$

528

 

 

$

295

 

General and administrative

 

 

2,000

 

 

 

1,626

 

 

 

1,319

 

Total stock-based compensation expense

 

$

2,600

 

 

$

2,154

 

 

$

1,614

 

 

Summary of Warrants Outstanding

Warrants

Warrants outstanding for the purchase of common stock as of December 31, 2023 were as follows:

 

Number

 

 

Exercise Price

 

 

Expiration

Outstanding

 

 

Per Share

 

 

Date

 

2,978

 

 

$

50.37

 

 

June 2024

 

2,886

 

 

$

51.98

 

 

December 2024

 

5,864

 

 

 

 

 

 

Summary of Common Stock Reserved for Future Issuance

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance was as follows:

 

 

December 31, 2023

 

Common stock warrants

 

 

5,864

 

Common stock options and restricted stock units

 

 

4,020,154

 

Shares available under the 2015 equity incentive plan

 

 

3,964,555

 

Shares available under the 2022 inducement plan

 

 

95,367

 

Shares available under the employee stock purchase plan

 

 

727,311

 

 

 

 

8,813,251

 

Employee Stock Option [Member]  
Summary of Assumptions Used to Determine Fair Value of Employee Stock Option Grants and Performance Options with Market Condition

The assumptions used in the Black-Scholes option pricing model to determine the fair value of the employee stock option grants were as follows:

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Expected term (in years)

 

5.51 – 6.09

 

 

5.98 – 6.08

 

 

5.50 – 6.08

 

Risk-free interest rate

 

3.58% – 4.5%

 

 

1.7% – 4.2%

 

 

0.6% – 1.3%

 

Expected volatility

 

81.5% – 83.0%

 

 

84.2% – 86.5%

 

 

86.3% – 104.8%

 

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%